These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31737208)

  • 1. Long noncoding RNA DLX6-AS1 targets miR-124-3p/CDK4 to accelerate Ewing's sarcoma.
    Lei X; Yang S; Yang Y; Zhang J; Wang Y; Cao M
    Am J Transl Res; 2019; 11(10):6569-6576. PubMed ID: 31737208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA DLX6-AS1 targets miR-124-3p/CDK4 to accelerate Ewing's sarcoma [Retraction].
    Am J Transl Res; 2023; 15(3):2280. PubMed ID: 37056831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
    Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
    Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
    Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
    Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing long non-coding RNA DLX6-AS1 or restoring microRNA-193b-3p enhances thyroid carcinoma cell autophagy and apoptosis via depressing HOXA1.
    Feng L; Wang R; Wang Y; Shen X; Shi Q; Lian M; Ma H; Fang J
    J Cell Mol Med; 2021 Oct; 25(19):9319-9330. PubMed ID: 34514705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury.
    Tan J; Fan J; He J; Zhao L; Tang H
    J Bioenerg Biomembr; 2020 Oct; 52(5):367-376. PubMed ID: 32666494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis.
    Liu L; Zhou T; Li T; Liang Z; Luo X
    Behav Brain Res; 2022 Aug; 431():113923. PubMed ID: 35550840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of DLX6-AS1 silencing against cerebral ischemia/reperfusion induced impairments.
    Hu X; Xiang Z; Zhang W; Yu Z; Xin X; Zhang R; Deng Y; Yuan Q
    Aging (Albany NY); 2020 Nov; 12(22):23096-23113. PubMed ID: 33216728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis.
    Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y
    Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DLX6-AS1 Promotes the Progression of Neuroblastoma by Activating STAT2 via Targeting miR-506-3p.
    Hu Y; Sun H; Hu J; Zhang X
    Cancer Manag Res; 2020; 12():7451-7463. PubMed ID: 32904436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer.
    Yang J; Ye Z; Mei D; Gu H; Zhang J
    Cancer Manag Res; 2019; 11():4209-4221. PubMed ID: 31118816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA DLX6-AS1/miR-141-3p axis regulates osteosarcoma proliferation, migration and invasion through regulating Rab10.
    Guo Q; Sun H; Zheng K; Yin S; Niu J
    RSC Adv; 2019 Oct; 9(58):33823-33833. PubMed ID: 35528911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SOX2 overlapping transcript acts as a miRNA sponge to promote the proliferation and invasion of Ewing's sarcoma.
    Ma L; Sun X; Kuai W; Hu J; Yuan Y; Feng W; Lu X
    Am J Transl Res; 2019; 11(6):3841-3849. PubMed ID: 31312393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-141-3p Enhanced Radiosensitivity of CRC Cells.
    Peng L; Li P; Peng Z
    Comb Chem High Throughput Screen; 2024; 27(1):118-126. PubMed ID: 37143278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer.
    Zhu X; Ma X; Zhao S; Cao Z
    Environ Toxicol; 2021 Mar; 36(3):308-319. PubMed ID: 33035382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA
    Sun W; Zhang L; Yan R; Yang Y; Meng X
    Onco Targets Ther; 2019; 12():3945-3954. PubMed ID: 31190891
    [No Abstract]   [Full Text] [Related]  

  • 17. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
    Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
    Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1.
    Li X; Zhang H; Wu X
    Gene; 2019 Feb; 686():1-7. PubMed ID: 30366080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.
    Li D; Tang X; Li M; Zheng Y
    J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway.
    Zhang L; He X; Jin T; Gang L; Jin Z
    Biomed Pharmacother; 2017 Dec; 96():884-891. PubMed ID: 29145165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.